COGT Cogent Biosciences, Inc.

Formerly Unum Therapeutics Inc., the company is a biotechnology company focused on developing precision therapies for genetically defined diseases.

$7.93  -0.01 (-0.13%)
As of 11/30/2021 15:59:58 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  03/29/2018
Outstanding shares:  39,851,022
Average volume:  631,574
Market cap:   $333,154,544
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    19240Q201
ISIN:        US19240Q2012
Sedol:      BLR6XK8
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   2.83
PS ratio:   0.00
Return on equity:   -29.76%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy